Jessie Yeung, CFA
Interim CFO and VP of Investor Relations and Finance
New York, New York, United States
Professional Overview
Jessie Yeung is an accomplished finance executive with a proven track record of driving strategic initiatives and delivering financial results in the biotechnology industry. As the Interim CFO and VP of Investor Relations and Finance at Legend Biotech, she leverages her expertise in corporate finance, investor relations, and financial planning to support the company's growth and enhance shareholder value.
Experience Summary
Current Role
As the Interim CFO at Legend Biotech, Jessie is responsible for overseeing the company's financial operations, including financial reporting, capital allocation, and risk management. In her role as VP of Investor Relations and Finance, she serves as the primary liaison between the company and the investment community, communicating financial performance and strategic initiatives to drive investor confidence.
Career Progression
Jessie's career journey has spanned various finance and investor relations roles within the biotechnology and pharmaceutical sectors. Prior to her current position, she served as the Executive Director of Finance at Legend Biotech, where she played a pivotal role in the company's successful IPO and expansion into new markets. Additionally, Jessie held the position of VP of Investor Relations and Corporate Finance at Rocket Pharmaceuticals, where she helped strengthen the company's capital structure and investor relations program.
Jessie's early career experience includes roles in equity research at leading financial institutions, such as Bank of America Merrill Lynch, Wells Fargo Securities, and J.P. Morgan, where she developed a deep understanding of the biotech and pharmaceutical industries.
Academic Background
Jessie holds a Bachelor of Science in Finance from the University of Pennsylvania's Wharton School and is a Chartered Financial Analyst (CFA) charterholder.
Areas of Expertise
- Corporate finance and strategic planning
- Investor relations and capital markets
- Financial reporting and analysis
- Risk management and compliance
- Mergers, acquisitions, and strategic partnerships
- Equity research and industry analysis
Professional Impact
During her tenure at Legend Biotech, Jessie has been instrumental in securing strategic partnerships, optimizing the company's capital structure, and enhancing its investor relations program. Her contributions have played a pivotal role in driving the company's growth and expanding its presence in the global biotechnology market.
Conclusion
With her exceptional financial acumen, strategic mindset, and deep industry knowledge, Jessie Yeung is well-positioned to continue driving the success of Legend Biotech as its Interim CFO and VP of Investor Relations and Finance. Her proven track record of delivering financial results and fostering strong investor relations makes her a valuable asset to the company and its stakeholders.
